Marco Colonna, MD
Professor, Washington University School of Medicine in St. Louis, Former Grantee
The Colonna lab is broadly interested in innate immunity, focused in two main areas related to IBD: 1) innate lymphoid cells in mucosal immunity and 2) plasmacytoid dendritic cells and IFNalpha/beta in host defense and autoimmunity.
Jason Cyster, PhD
Professor, University of California, San Francisco, Current Grantee
The Cyster Lab deciphers the molecular cues that guide leukocyte migration and interaction events during tissue surveillance and immune response. They’re working to visualize immune response dynamics using advanced imaging and cell engineering.
Rafael Czepielewski, PhD
Assistant Professor, Augusta University Research Institute Inc, Current Grantee
The Czepielewski Lab investigates how chronic intestinal inflammation disrupts mucosal immune balance and tolerance by remodeling the lymphatic vasculature in Inflammatory Bowel Diseases, aiming to unravel new mechanisms to restore barrier health.
Michael Davis, PhD
Professor, University of Missouri, Former Grantee
Dr. Davis’s lab focuses on the mechanical and electrophysiological properties of lymphatic smooth muscle and endothelium and how dysfunction of those cell types contributes to lymphedema.
Lee Denson, MD
Professor, Cincinnati Children’s Hospital Medical Center, Current Grantee
Dr. Denson’s multi-center research program focuses on discovering underlying mechanisms and better therapeutic approaches in chronic inflammation, growth and mucosal healing related to adult and pediatric patients with IBD.
Gretchen Diehl, PhD
Associate Professor, Memorial Sloan Kettering Cancer Center, Former Grantee
The Gretchen Diehl lab aims to understand the cellular and molecular processes limiting inflammation against the microbiota, with a focus on CX3CR1 expressing mononuclear phagocyte, a cell lineage they believe is critical in regulating homeostasis.
